Analyzing Green Organic Dutchman (OTCMKTS:TGODF) and H. Lundbeck A/S (OTCMKTS:HLUYY)

H. Lundbeck A/S (OTCMKTS:HLUYY) and Green Organic Dutchman (OTCMKTS:TGODF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, dividends and risk.

Volatility and Risk

H. Lundbeck A/S has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Green Organic Dutchman has a beta of 2.27, indicating that its stock price is 127% more volatile than the S&P 500.

Valuation and Earnings

This table compares H. Lundbeck A/S and Green Organic Dutchman”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
H. Lundbeck A/S	$2.59 billion	8.45	$209.69 million	$0.88	25.00
Green Organic Dutchman	$24.13 million	0.04	-$33.62 million	($0.41)	-0.03

H. Lundbeck A/S has higher revenue and earnings than Green Organic Dutchman. Green Organic Dutchman is trading at a lower price-to-earnings ratio than H. Lundbeck A/S, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for H. Lundbeck A/S and Green Organic Dutchman, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
H. Lundbeck A/S	1	1	0	0	1.50
Green Organic Dutchman	0	0	0	0	N/A

Profitability

This table compares H. Lundbeck A/S and Green Organic Dutchman’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
H. Lundbeck A/S	6.74%	13.74%	7.16%
Green Organic Dutchman	-83.86%	-22.02%	-14.58%

Insider and Institutional Ownership

0.4% of Green Organic Dutchman shares are owned by institutional investors. 8.7% of Green Organic Dutchman shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

H. Lundbeck A/S beats Green Organic Dutchman on 8 of the 11 factors compared between the two stocks.

About H. Lundbeck A/S

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

About Green Organic Dutchman

The Green Organic Dutchman Holdings Ltd. engages in the production, cultivation, processing, and distribution of cannabis and related products. Its products include cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis. The company was founded by Scott Skinner and Jeannette VanderMarel in 2012 and is headquartered in Mississauga, Canada.